Camptodactyly arthropathy coxa vara pericarditis syndrome

What causes camptodactyly-arthropathy-coxa vara-pericarditis syndrome?

Camptodactyly-arthropathy-coxa-pericarditis syndrome is caused by a change (mutation) in the PRG4 gene. This gene provides the instructions for making lubricin, a protein (part of synovial fluid) that lubricates the joints. In other words, lubricin works like oil in a hinge and is needed so the joints can bend easily without a lot of force or causing damage to the bones. Lubricin also works as an lubricant between the two layers of the thin sac which surrounds the heart (pericardium). The pericardium holds the heart in place and helps it work properly. In addition lubricin keeps the thin coverings of tendons (tendon sheaths) from sticking to the thin fibrous coverings (sheaths) of muscles and organs as well as controls cell growth of special cells (synovial fibroblasts) which are part of the thin covering (synovial membrane) surrounding the synovial fluid within joints. **


Last updated on 05-01-20

How might camptodactyly-arthropathy-coxa vara-pericarditis syndrome CACP) be diagnosed?

Diagnosis of CACP is based on clinical findings (symptoms which the doctor notices during a physical exam), X-rays of the joints, cardiac ultrasound (also called an echocardiogram), and a biopsy of the fluid between the joints (synovial fluid). Genetic testing can confirm the diagnosis. CACP may at first be confused with juvenile idiopathic arthritis (JIA) because the two diseases may have similar symptoms.

Last updated on 05-01-20

How is camptodactyly-arthropathy-coxa vara-pericarditis syndrome (CACP) inherited?

The condition is inherited in an autosomal recessive manner. This means that to be affected, a person must have a mutation in both copies of the PRG4gene in each cell. People with CACP inherit one mutated copy of the gene from each parent, who is referred to as a carrier. Carriers of an autosomal recessive condition typically do not have any signs or symptoms (they are unaffected). When two carriers of an autosomal recessive condition have children, each child has a:

  • 25% chance to be affected (have CACP)
  • 50% chance to be an unaffected carrier like each parent
  • 25% chance to be unaffected and not a carrier

Last updated on 05-01-20

How might camptodactyly-arthropathy-coxa vara-pericarditis syndrome (CACP) be treated?

At present there is no cure or specific treatment for camptodactyly- arthropathy-coxa vara-pericarditis syndrome (CACP). Treatment options such as physical therapy and pain medication focus on relieving the symptoms of the disease. Hip joint replacement surgery may also be an option. The medication for juvenile idiopathic arthritis is not helpful for those with CACP.

Last updated on 05-01-20

Connect with other users with Camptodactyly arthropathy coxa vara pericarditis syndrome on the RareGuru app

Do you have information about a disease, disorder, or syndrome? Want to suggest a symptom?
Please send suggestions to RareGuru!

The RareGuru disease database is regularly updated using data generously provided by GARD, the United States Genetic and Rare Disease Information Center.

People Using the App

Join the RareGuru Community

To connect, share, empower and heal today.

People Using the App